Skip to main content
Fig. 4 | Journal for ImmunoTherapy of Cancer

Fig. 4

From: Agonist anti-GITR antibody significantly enhances the therapeutic efficacy of Listeria monocytogenes-based immunotherapy

Fig. 4

Six days after the second treatment with Listeria-based immunotherapy treatment, mice were euthanized and tumors harvested and profiled for a. total number of GR1+CD11b+ MDSCs per 1e6 tumor cells. Ratios for CD8+/MDSCs (b) and CD8+E7+/MDSCs (c) were calculated. (*P ≤ 0.05, ** P ≤ 0.01, ***P ≤ 0.001). Experiment was repeated twice with n = 5/group with similar results

Back to article page